Chronic lymphocytic leukemia (CLL), a CD5+ mature B-cell malignancy, has long been considered an incurable disease, and its treatment was focused on symptom control rather than on survival prolongation. Here, CD5 is linked to B-cell chronic lymphocytic leukemia.